Released on = December 7, 2005, 3:22 am

Press Release Author = IT.Omics / OmniViz / Milestones

Industry = Pharmaceuticals

Press Release Summary = IT.Omics, provider of the LS-Graph® network analysis
software, and OmniViz, Inc., a leading provider of software and components for
visual mining of complex data, announced a collaboration which aims to increase
creativity and efficiency in the drug development process.

Press Release Body = Lille (France) - December 7, 2005 - IT.Omics, provider of the
LS-Graph® network analysis software, and OmniViz, Inc., a leading provider of
software and components for visual mining of complex data, announced a
collaboration during the European Biotech Crossroads meeting last week. The
collaboration aims to increase creativity and efficiency in the drug development
process through a tighter coupling of advanced visualization and analysis of
experimental data with knowledge-based data mining and the building of systems
biology networks.

IT.Omics' LS-Graph® technology consists of automated information extraction for the
generation of global knowledge graphs from various sources, with a coverage and
flexibility beyond that of standard curated databases. Providing critical insight
into regulatory mechanisms, the resulting networks help researchers focus on high
value-added targets as well as better understand mechanisms of action and side
effects.

The OmniViz® software provides unique high-level visualization of multi-dimensional
data enabling researchers to better characterize their results, discover novel
relationships, and test emerging hypotheses. Typical sources of input include
biological and chemical experimental data, toxicology results, clinical trial and
marketing information, as well as the global biomedical and patent literature.

"Enabling users of LS-Graph® to seamlessly couple into the unique OmniViz
visualization and mining software will expand the scope of LS-Graph and provide a
framework that supports rapid and more efficient decision-making," said Emmanuel
Jospin, CEO of IT.Omics. "The extensive knowledge extraction and analysis
represented by LS-Graph® provides a synergistic framework for the interpretation of
relationships observed in OmniViz® visualizations," said Jeffrey D. Saffer,
President of OmniViz, Inc.


About IT.Omics

IT.Omics (http://www.it-omics.com) is a Lille, France-based bioinformatics company
dedicated to the design and development of integrated bioinformatics solutions that
enhance the drug development process. Utilizing state-of-the-art technologies of
data mining, data analysis and knowledge management, these solutions help better
understand the pathogenesis of disease and drug mechanisms of action, select and
prioritize therapeutic targets and drug candidates, access key sources of
information fast and easy, both "system-oriented" (i.e., focused on networks among
biological entities) and contextualized to their fields of interest.

About OmniViz, Inc.
OmniViz, Inc. (http://www.omniviz.com), is a leader in the mining and visualization
of vast and disparate data sets for faster and more efficient decision-making. Its
proprietary technologies provide Visual Intelligence, enabling analysis of the very
large and varied sorts of data sets currently at the disposal of researchers in
large discovery organizations, leading to increased productivity, decreasing time to
market, and reducing business risks.

LS-Graph is a registered trademark of IT.Omics OmniViz is a registered trademark
of OmniViz, Inc.


Web Site = http://www.it-omics.com

Contact Details = Contacts

IT.Omics
Emmanuel Jospin - CEO
emmanuel.Jospin@it-omics.com
Tél. : +33 (0)3 20 16 40 50

OmniViz
Jeff Saffer - Ph.D, President and CTO
saffer@omniviz.com.
Tél. : 978-461-1256?
Milestones
Bruno Arabian, press relations
milestones@milestones-fr.com
Tél. : +33 (0)1 70 08 04 13 /+33 (0)6 87 88 47 26